Canaccord Genuity Builds Investment Banking Team

Canaccord Genuity (CG) has appointed Mark Turco and James “Jim” Schroder as Managing Directors within its U.S. investment banking platform.

Mr. Turco will be based in Washington DC, focusing on healthcare services and digital and tech-enabled healthcare, while Mr. Schroder, located in San Francisco, will focus coverage on B2B SaaS and enterprise software.

Mr. Turco brings nearly 20 years of healthcare investment banking experience to CG. Most recently, he was a Managing Director at Ziegler where he led more than 35 M&A and capital raising transactions spanning revenue cycle management, digital health, data analytics, federal health IT, post-acute technology, payments, and business process outsourcing. Earlier in his career, he was in the investment banking division at Alvarez & Marsal with a focus on financial restructurings and M&A. Mr. Turco has his undergraduate degree in history from Yale University.

“Mark’s appointment not only deepens the expertise of our current team but also expands our reach into an important area of healthcare services, where there remains significant opportunity for ongoing transaction activity across M&A and ECM,” the firm stated in a released statement.

Mr. Schroder joins CG with over 25 years of investment banking experience in software and technology. Before joining, he co-led the software team at Stifel, following its 2019 acquisition of Mooreland Partners.

Earlier in his career, he was a partner at Arma Partners where he led the firm’s U.S. technology M&A business in Palo Alto, and a senior banker at Lehman Brothers with roles in New York, London, and Menlo Park. Over his career, Mr. Schroder has executed over 100 software sell-side M&A transactions totaling more than $35 billion. He has his undergraduate degree in systems engineering from the U.S. Naval Academy and an MBA from Yale University.

“Jim’s appointment enhances our technology franchise by expanding our expertise in these high-growth areas and strengthening our ability to deliver strategic insights and solutions to our clients,” the firm stated in a released statement.

Canaccord Genuity Capital Markets is the global capital markets division of Canaccord Genuity (TSX: CF), offering institutional and corporate clients idea-driven investment banking, mergers and acquisitions (M&A), research, sales and trading services with capabilities in North America, the UK and Europe, Asia, and Australia.

Canaccord Genuity provides investment banking, advisory, and capital markets services to growth companies globally. Headquartered in Toronto, the firm maintains operations across the U.S., U.K., and Canada, with sector coverage in healthcare, technology, consumer, and industrials.

Canaccord Genuity’s U.S. investment banking division has actively recruited seasoned professionals in recent years as part of a broader strategy to expand its advisory franchise.